‘Little evidence’ of vitamin D helping inflammatory biomarkers in elderly

By Annie Harrison-Dunn contact

- Last updated on GMT

Results highlight uncertainty surrounding the effectiveness of vitamin D supplementation in improving inflammatory biomarker
Results highlight uncertainty surrounding the effectiveness of vitamin D supplementation in improving inflammatory biomarker

Related tags: Vitamin d supplementation, Immune system, Vitamin d

Researchers have questioned the association between vitamin D and inflammatory biomarkers after a year-long trial revealed no impact on the levels of the immune system’s cytokine or adipokine.

The research, published in the British Journal of Nutrition​, used 644 60- to 84-year-old volunteers. They were assigned to a placebo group or received 750 micrograms (μg) or 1500 μg of vitamin D3 per month for 12 months.

The researchers wrote: “With the possible exception of IL-6, we found little evidence of an effect of vitamin D supplementation on cytokine or adipokine levels.

“These results highlight the uncertainty surrounding the effectiveness of vitamin D supplementation in improving inflammatory biomarker profiles and the need to better understand the effects of vitamin D supplementation before recommending that it is routinely used in the general population.”

The Australian researchers said their study was one of the largest and, therefore “most highly powered”​ studies on vitamin D and inflammation, with relevance that went beyond the highly specific patient groups used in earlier research.

The results questioned observational studies in the past which had suggested vitamin D serum levels were associated with inflammatory markers through various mechanisms.

Chronic inflammation underlies many pathological processes including several types of cancer, cardiovascular disease and autoimmune disease. Interleukin 6 (IL-6) has both pro-inflammatory  and anti-inflammatory functions in its cytokine andmyokine role.

The study was conducted by researchers from the QIMR Berghofer Medical Research Institute, Centre for Research Excellence in Sun and Health, Centre for Big Data Research in Health at the University of New South Wales, University of Melbourne, Cancer Council Victoria, Australian National University, University of Western Australia and the University of Tasmania in Australia.

 

Source: British Journal of Nutrition

Published online ahead of print, doi:10.1017/S0007114515002366

“Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial”

Author: M. Waterhouse, B. Tran, P. R. Ebeling, D. R. English, R. M. Lucas, A. J. Venn, P. M. Webb, D. C. Whiteman ​and R. E. Neale

Related news

Show more

Related products

show more

Proven Efficacy of Delphinol® on Bone Health

Proven Efficacy of Delphinol® on Bone Health

Anklam Extrakt GmbH | 21-Oct-2019 | Research Study

Within the course of a preclinical study covering in vitro and in vivo analyses, the effect of a polyphenol-rich maqui berry extract (Delphinol®) on bone...

20 Years Palm Tocotrienols Brain Health Research

20 Years Palm Tocotrienols Brain Health Research

ExcelVite Sdn. Bhd. | 25-Sep-2019 | Technical / White Paper

Research of Vitamin E tocotrienol in brain health and neuroprotection began twenty years ago.
Today, other health benefits have been discovered...

Related suppliers

4 comments

Show more

Really?

Posted by Phil,

You can't really take this study seriously at all. With maximum dosages of 1.5mg per month, I don't know why a study with a monthly dose that low was given any credibility at all. I hope it was a misprint, but checked the source and it is the same.

Report abuse

VitD dose way too low

Posted by Josh Reynolds,

1500mcg is about 5000IU. IF the report isn't a misprint, 1550ug a month is woefully low. At 1500 a day, or even week results might have been significantly different

Report abuse

Vitamin D and elderly

Posted by cynthia dann-beardsley,

The dosage was too low to improve almost anything. Most elderly people are severely D deficient to begin with and require more than the trial amounts to effect considerable change. IOM guidelines fail to address latitude factor.

Report abuse

Follow us

Featured Events

View more

Products

View more

Webinars